T.-T. Li et al. / Tetrahedron 71 (2015) 7003e7009
7007
52.5, 48.0, 19.5. NMR data were in agreement with reported
chromatography
(petroleum
ether/ethyl
acetate¼10:1);
results.27
mp¼83e85 ꢀC. 1H NMR (400 MHz, CDCl3)
¼8.51e8.41 (m, 1H),
d
7.55 (td, J¼7.7, 1.7 Hz,1H), 7.36 (d, J¼7.8 Hz, 1H), 7.22e6.93 (m, 12H),
4.08 (d, J¼14.4 Hz, 1H), 3.60 (d, J¼9.9 Hz, 1H), 3.51 (d, J¼14.4 Hz,
1H), 2.94 (d, J¼9.9 Hz, 1H), 2.86e2.73 (m, 1H), 2.20 (dd, J¼12.3,
7.7 Hz, 1H), 1.10 (d, J¼5.8 Hz, 3H). 13C NMR (100 MHz, CDCl3)
4.3.4. 1-(4-Fluorobenzyl)-2-methyl-4,4-diphenylpyrrolidine
(3d). Compound 3d was prepared according to the general pro-
cedure and isolated as a white solid (153 mg, 89%) after column
chromatography (petroleum ether/ethyl acetate¼20:1); mp¼91 ꢀC.
d
¼160.5, 150.3, 148.9, 148.4, 136.4, 128.2, 127.9, 127.2, 125.9, 125.5,
1H NMR (400 MHz, CDCl3)
d
¼7.33e7.12 (m, 12H), 6.98 (t, J¼8.7 Hz,
122.8, 121.8, 66.5, 59.7, 59.7, 52.9, 47.8, 19.5. NMR data were in
agreement with reported results.9b
2H), 4.00 (d, J¼13.2 Hz, 1H), 3.59 (d, J¼9.8 Hz, 1H), 3.21 (d,
J¼13.2 Hz, 1H), 2.90 (dd, J¼12.7, 7.8 Hz, 1H), 2.81 (dd, J¼13.6, 7.5 Hz,
1H), 2.75 (d, J¼9.8 Hz, 1H), 2.20 (dd, J¼12.7, 7.7 Hz, 1H), 1.14 (d,
4. 3.10. 1-Isopropyl-2-methyl-4, 4-diphenylpyrrolidine
(3j). Compound 3j was prepared according to the general pro-
cedure and isolated as an oil (133 mg, 91%) after column chroma-
tography (petroleum ether/ethyl acetate¼5:1); 1H NMR (400 MHz,
J¼6.0 Hz, 3H). 13C NMR (100 MHz, CDCl3)
¼150.5, 148.6, 135.8,
d
135.8, 130.0, 128.1, 127.8, 127.4, 127.2, 125.8, 125.4, 115.0, 66.3, 59.6,
57.2, 52.5, 47.9, 19.5. NMR data were in agreement with reported
results.9d
CDCl3)
d
¼7.61e6.92 (m, 10H), 3.90 (d, J¼9.6 Hz, 1H), 2.92 (dd,
J¼12.8, 7.6 Hz, 1H), 2.84 (d, J¼9.6 Hz, 1H), 2.77e2.65 (m, 1H), 2.48 (t,
J¼11.0 Hz, 1H), 2.26e2.10 (m, 2H), 1.94e1.77 (m, 1H), 1.16 (d,
J¼6.0 Hz, 3H),1.05 (t, J¼10.5 Hz, 3H), 0.99 (d, J¼6.6 Hz, 3H). 13C NMR
4.3.5. 1-(4-Chlorobenzyl)-2-methyl-4,4-diphenylpyrrolidine
(3e). Compound 3e was prepared according to the general pro-
cedure and isolated as a white solid (171 mg, 95%) after column
(100 MHz, CDCl3)
d
¼151.4, 148.9, 128.2, 127.9, 127.7, 127.4, 125.9,
chromatography
(petroleum
ether/ethyl
acetate¼20:1);
125.5, 67.5, 62.7, 60.3, 52.8, 48.1, 27.8, 21.5, 21.0,19.7. NMR data were
mp¼90e91 ꢀC. 1H NMR (400 MHz, CDCl3)
d
¼7.18e6.98 (m, 14H),
in agreement with reported results.9d
3.90 (d, J¼13.4 Hz,1H), 3.50 (d, J¼9.8 Hz,1H), 3.11 (d, J¼13.4 Hz,1H),
2.80 (dd, J¼12.6, 7.8 Hz, 1H), 2.72 (ddd, J¼13.7, 9.7, 3.6 Hz, 1H), 2.66
(d, J¼9.8 Hz, 1H), 2.11 (dd, J¼12.6, 7.6 Hz, 1H), 1.04 (d, J¼5.9 Hz, 3H).
4.3.11. 1-Butyl-2-methyl-4,4-diphenylpyrrolidine (3k). Compound
3k was prepared according to the general procedure and isolated as
an oil (114 mg, 78%) after column chromatography (petroleum
13C NMR (100 MHz, CDCl3)
d
¼150.5, 148.7, 138.8, 132.5, 130.0, 128.4,
128.3, 128.0, 127.5, 127.3, 126.0, 125.6, 66.5, 59.7, 57.4, 52.7, 48.0,
19.6. NMR data were in agreement with reported results.16
ether/ethyl acetate¼40:1); 1H NMR (400 MHz, CDCl3)
¼7.53e6.86
d
(m, 10H), 3.91 (d, J¼9.9 Hz, 1H), 2.90e2.70 (m, 3H), 2.64 (dd, J¼13.9,
7.6 Hz, 1H), 2.21e2.03 (m, 2H), 1.56e1.50 (m, 2H), 1.38e1.34 (m,
2H), 1.09 (d, J¼6.1 Hz, 3H), 0.93 (t, J¼7.3 Hz, 3H). 13C NMR (100 MHz,
4.3.6. 1-(4-Nitrobenzyl)-2-methyl-4,4-diphenylpyrrolidine
(3f). Compound 3f was prepared according to the general pro-
cedure and isolated as a white solid (158 mg, 85%) after column
CDCl3)
d
¼150.8, 148.9, 128.2, 127.9, 127.5, 127.2, 125.8, 125.4, 66.8,
60.4, 53.9, 52.6, 48.0, 31.1, 20.9, 19.4, 14.1. HRMS-ESI (m/z): [MþH]þ
chromatography
(petroleum
ether/ethyl
acetate¼15:1);
calcd for C21H27N, 294.2195; found: 294.2220.
mp¼123e124 ꢀC. 1H NMR (400 MHz, CDCl3)
d¼8.15 (d, J¼8.6 Hz,
2H), 7.50 (d, J¼8.4 Hz, 2H), 7.28e7.10 (m, 10H), 4.10 (d, J¼14.3 Hz,
1H), 3.59 (d, J¼9.7 Hz, 1H), 3.40 (d, J¼14.3 Hz, 1H), 2.95e2.86 (m,
2H), 2.84 (d, J¼9.7 Hz, 1H), 2.27 (q, J¼11.0 Hz, 1H), 1.17 (d, J¼5.5 Hz,
4.3.12. 1-Allyl-2-methyl-4,4-diphenylpyrrolidine (3l). Compound 3l
was prepared according to the general procedure and isolated as
a white solid (130 mg, 94%) after column chromatography (petro-
leum ether/ethyl acetate¼30:1); mp¼62e63 ꢀC. 1H NMR (400 MHz,
3H). 13C NMR (100 MHz, CDCl3)
d
¼150.0, 148.3, 148.2, 147.0, 129.0,
128.2, 127.9, 127.3, 127.0, 126.0, 125.7, 123.5, 66.4, 59.7, 57.3, 52.7,
47.6, 19.5. NMR data were in agreement with reported results.27
CDCl3)
d
¼7.26e6.94 (m, 10H), 5.97e5.75 (m, 1H), 5.19e4.90 (m,
2H), 3.76 (d, J¼10.0 Hz, 1H), 3.56e3.34 (m, 1H), 2.83e2.65 (m, 3H),
2.67e2.56 (m, 1H), 2.09 (dd, J¼12.9, 8.2 Hz, 1H), 1.03 (d, J¼6.1 Hz,
4.3.7. 1-(4-Cyanobenzyl)-2-methyl-4,4-diphenylpyrrolidine
(3g). Compound 3g was prepared according to the general pro-
cedure and isolated as a white solid (158 mg, 90%) after column
3H). 13C NMR (100 MHz, CDCl3)
d
¼149.5, 147.8, 135.5, 127.1, 126.9,
126.4, 126.1, 124.8, 124.4, 115.5, 65.6, 58.6, 55.9, 51.5, 47.0, 18.3.
HRMS-ESI (m/z): [MþH]þ calcd for C20H24N, 278.1895; found:
278.1907.
chromatography
(petroleum
ether/ethyl
acetate¼40:1);
mp¼102e104 ꢀC. 1H NMR (400 MHz, CDCl3)
d
¼7.54e7.05 (m, 14H),
4.00 (d, J¼14.2 Hz, 1H), 3.50 (d, J¼9.7 Hz, 1H), 3.28 (d, J¼14.2 Hz,
1H), 2.87e2.70 (m, 3H), 2.27e2.08 (m, 1H), 1.08 (d, J¼5.8 Hz, 3H).
4.3.13. 1-Benzyl-2-methyl-5,5-diphenylpiperidine (3m). Compound
3m was prepared according to the general procedure and isolated
as an oil (126 mg, 74%) after column chromatography (petroleum
13C NMR (100 MHz, CDCl3)
d
¼150.0, 148.4, 146.1, 132.1, 129.0, 128.2,
127.9, 127.3, 127.1, 126.0, 125.6, 119.0, 110.6, 66.5, 59.7, 57.6, 52.7,
ether/ethyl acetate¼50:1); 1H NMR (400 MHz, CDCl3)
¼7.40e6.93
d
47.7, 19.5. NMR data were in agreement with reported results.27
(m, 15H), 4.04 (d, J¼13.3 Hz, 1H), 3.35 (d, J¼12.2 Hz, 1H), 3.13 (d,
J¼13.3 Hz, 1H), 2.51e2.37 (m, 3H), 2.23e2.09 (m, 1H), 1.64e1.56
(m, 1H), 1.36 (ddd, J¼24.7, 9.4, 3.2 Hz, 1H), 1.13 (d, J¼6.1 Hz, 3H).
4.3.8. 1-(4-Isopropylbenzyl)-2-methyl-4,4-diphenylpyrrolidine
(3h). Compound 3h was prepared according to the general pro-
cedure and isolated as an oil (166 mg, 90%) after column chroma-
tography (petroleum ether/ethyl acetate¼20:1); 1H NMR
13C NMR (100 MHz, CDCl3)
d¼147.5, 145.7, 138.4, 129.0, 128.5,
127.4, 126.9, 126.6, 126.0, 125.8, 124.6, 124.3, 59.9, 57.9, 55.1, 45.5,
33.2, 29.9, 17.6. NMR data were in agreement with reported
results.28
(400 MHz, CDCl3)
d
¼7.46e6.93 (m, 14H), 4.04 (d, J¼13.3 Hz, 1H),
3.65 (d, J¼9.9 Hz, 1H), 3.21 (d, J¼13.3 Hz, 1H), 2.90e2.85 (m, 2H),
2.81e2.76 (m, 2H), 2.19 (dd, J¼12.5, 7.8 Hz, 1H), 1.24 (dd, J¼6.9,
1.5 Hz, 6H), 1.14 (dd, J¼5.9, 1.4 Hz, 3H). 13C NMR (100 MHz, CDCl3)
4.3.14. 1-(4-Methylbenzyl)-2-methyl-5,5-diphenylpiperidine
(3n). Compound 3n was prepared according to the general pro-
cedure and isolated as an oil (151 mg, 85%) after column chroma-
tography (petroleum ether/ethyl acetate¼40:1); 1H NMR
d
¼149.7, 147.7, 146.2, 136.3, 127.4, 127.0, 126.7, 126.4, 126.2, 125.2,
124.7, 124.3, 65.4, 58.5, 56.6, 51.5, 47.0, 32.7, 23.1, 23.0,18.5. NMR
data were in agreement with reported results.19
(400 MHz, CDCl3)
d
¼7.47e7.15 (m,14H), 4.15 (d, J¼13.2 Hz,1H), 3.50
(d, J¼12.3 Hz, 1H), 3.24 (d, J¼13.2 Hz, 1H), 2.56e2.55 (m, 3H), 2.50
(s, 3H), 2.30 (t, J¼11.8 Hz, 1H), 1.78e1.71 (m, 1H), 1.55e1.43 (m, 1H),
4.3.9. 1-(2-Pyridinyl)methyl-2-methyl-4,4-diphenylpyrrolidine
(3i). Compound 3i was prepared according to the general pro-
cedure and isolated as a white solid (149 mg, 91%) after column
1.27 (dd, J¼6.1, 1.8 Hz, 3H). 13C NMR (100 MHz, CDCl3)
¼147.6,
d
145.7, 135.2, 128.4, 127.7, 127.5, 127.2, 126.9, 126.6, 126.0, 124.6,